0001437749-23-028074.txt : 20231011 0001437749-23-028074.hdr.sgml : 20231011 20231011214202 ACCESSION NUMBER: 0001437749-23-028074 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231001 FILED AS OF DATE: 20231011 DATE AS OF CHANGE: 20231011 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Powchik Peter CENTRAL INDEX KEY: 0001377247 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41058 FILM NUMBER: 231321636 MAIL ADDRESS: STREET 1: REGENERON PHARMACEUTICALS, INC. STREET 2: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Vaxxinity, Inc. CENTRAL INDEX KEY: 0001851657 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 862083865 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 505 ODYSSEY WAY CITY: EXPLORATION PARK STATE: FL ZIP: 32953 BUSINESS PHONE: (254) 244-5739 MAIL ADDRESS: STREET 1: 505 ODYSSEY WAY CITY: EXPLORATION PARK STATE: FL ZIP: 32953 4 1 rdgdoc.xml FORM 4 X0508 4 2023-10-01 0001851657 Vaxxinity, Inc. VAXX 0001377247 Powchik Peter 505 ODYSSEY WAY MERRITT ISLAND FL 32953 1 0 Stock option (right to buy) 1.27 2023-10-02 4 A 0 159744 0 A Class A common stock 159744 159744 D These options were granted following the Reporting Person joining the Issuer's leadership team as Executive Vice President, Global Scientific Director, effective October 1, 2023, while remaining a member of the Issuer's board of directors. These options vest in 12 equal monthly installments beginning on October 1, 2023. These stock options shall expire upon the earlier of (i) the tenth anniversary of the grant date, and (ii) three months after the date the Reporting Person ceases to be a director, officer, employee or consultant of the Issuer or one of its affiliates. /s/ Rene Paula Molina, attorney-in-fact for Peter Powchik 2023-10-11